ARDX Ardelyx, Inc.
Healthcare$6.25+2.29%ClosedMarket Cap: $1.54B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
10.11
P/S
3.53
EV/EBITDA
-49.53
DCF Value
$-220.62
FCF Yield
-2.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
91.9%
Operating Margin
-8.7%
Net Margin
-13.6%
ROE
-38.1%
ROA
-11.5%
ROIC
-9.4%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $94.5M | 94.9% | $-32.8M | $-37.6M | $— | — |
| Q4 null | $125.2M | 90.6% | $5.1M | $-407.0K | $— | — |
| FY null | $407.3M | 89.5% | $-41.0M | $-61.6M | $— | — |
| Q3 null | $110.3M | 95.6% | $4.7M | $-969.0K | $— | — |
| Q2 null | $97.7M | 86.7% | $-14.4M | $-19.1M | $— | — |
| Q1 null | $74.1M | 82.6% | $-36.3M | $-41.1M | $— | — |
| Q4 null | $116.1M | 84.3% | $8.1M | $4.6M | $— | — |
| FY null | $333.6M | 84.8% | $-27.9M | $-39.1M | $— | — |
| Q3 null | $98.2M | 84.0% | $2.2M | $-809.0K | $— | — |
| Q2 null | $73.2M | 86.3% | $-13.6M | $-16.5M | $— | — |
| Q1 null | $46.0M | 83.6% | $-24.7M | $-26.5M | $— | — |
| Q4 2023 | $34.4M | 85.2% | $-28.0M | $-28.8M | $-0.12 | — |